[{"address1": "2000 Sierra Point Parkway", "address2": "Suite 400", "city": "Brisbane", "state": "CA", "zip": "94005", "country": "United States", "phone": "415 798 8589", "website": "https://www.tempesttx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California.", "fullTimeEmployees": 24, "companyOfficers": [{"maxAge": 1, "name": "Mr. Stephen R. Brady J.D., LLM", "age": 54, "title": "CEO, President & Director", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 894300, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Nicholas  Maestas", "age": 44, "title": "CFO, Head of Corporate Strategy & Secretary", "yearBorn": 1980, "fiscalYear": 2024, "totalPay": 465615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Samuel  Whiting M.D., Ph.D.", "age": 58, "title": "Executive VP, Chief Medical Officer and Head of R&D", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 671387, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Justin  Trojanowski CPA", "age": 35, "title": "Corporate Controller, Treasurer & Principal Accounting Officer", "yearBorn": 1989, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.16, "open": 3.16, "dayLow": 3.0601, "dayHigh": 3.18, "regularMarketPreviousClose": 3.16, "regularMarketOpen": 3.16, "regularMarketDayLow": 3.0601, "regularMarketDayHigh": 3.18, "payoutRatio": 0.0, "beta": -2.257, "forwardPE": -2.253623, "volume": 42719, "regularMarketVolume": 42719, "averageVolume": 107055, "averageVolume10days": 142400, "averageDailyVolume10Day": 142400, "bid": 3.09, "ask": 3.16, "bidSize": 1, "askSize": 1, "marketCap": 15323470, "fiftyTwoWeekLow": 3.0, "fiftyTwoWeekHigh": 13.65, "allTimeHigh": 162893.25, "allTimeLow": 2.21, "fiftyDayAverage": 8.0752, "twoHundredDayAverage": 8.265985, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 14699901, "profitMargins": 0.0, "floatShares": 4191112, "sharesOutstanding": 4927161, "sharesShort": 379220, "sharesShortPriorMonth": 156075, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.077, "heldPercentInsiders": 0.00099, "heldPercentInstitutions": 0.1189, "shortRatio": 2.14, "shortPercentOfFloat": 0.077, "impliedSharesOutstanding": 4927161, "bookValue": 1.429, "priceToBook": 2.176347, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -36054000, "trailingEps": -9.73, "forwardEps": -1.38, "lastSplitFactor": "1:13", "lastSplitDate": 1744156800, "enterpriseToEbitda": -0.406, "52WeekChange": -0.6961539, "SandP52WeekChange": 0.13613915, "quoteType": "EQUITY", "currentPrice": 3.11, "recommendationKey": "none", "totalCash": 7514000, "totalCashPerShare": 1.692, "ebitda": -36166000, "totalDebt": 8405000, "quickRatio": 2.132, "currentRatio": 2.299, "debtToEquity": 132.446, "returnOnAssets": -0.89316005, "returnOnEquity": -4.0503297, "freeCashflow": -20340750, "operatingCashflow": -33395000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "TPST", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Tempest Therapeutics, Inc.", "longName": "Tempest Therapeutics, Inc.", "prevName": "Tempest Therapeutics Inc.", "nameChangeDate": "2025-12-12", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1352730600000, "postMarketChangePercent": -0.97748554, "postMarketPrice": 3.0796, "postMarketChange": -0.0303998, "regularMarketChange": -0.0500002, "regularMarketDayRange": "3.0601 - 3.18", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 107055, "fiftyTwoWeekLowChange": 0.109999895, "fiftyTwoWeekLowChangePercent": 0.03666663, "fiftyTwoWeekRange": "3.0 - 13.65", "fiftyTwoWeekHighChange": -10.54, "fiftyTwoWeekHighChangePercent": -0.7721612, "fiftyTwoWeekChangePercent": -69.61539, "dividendDate": 1544400000, "earningsTimestampStart": 1762981200, "earningsTimestampEnd": 1762981200, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -9.73, "epsForward": -1.38, "fiftyDayAverageChange": -4.9652004, "fiftyDayAverageChangePercent": -0.61487025, "twoHundredDayAverageChange": -5.155985, "twoHundredDayAverageChangePercent": -0.6237593, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "corporateActions": [], "postMarketTime": 1765586054, "regularMarketTime": 1765573200, "exchange": "NCM", "messageBoardId": "finmb_552715229", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.58228, "regularMarketPrice": 3.11, "marketState": "CLOSED", "displayName": "Tempest Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-12-13"}]